Movicol (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polyethylene glycol that is not absorbed from the gut. It retains water in the intestinal lumen by osmosis, softening the stool and stimulating peristalsis, while the added electrolytes help maintain fluid balance.

The dose of Movicol is individualized. A qualified prescriber determines the appropriate amount based on the patient’s age, severity of constipation and clinical condition. Patients should follow the specific instructions provided by their healthcare professional.

Safety data for Movicol during pregnancy and lactation are limited. It should only be used if the potential benefit outweighs any possible risk, and only under the guidance of a qualified healthcare provider.

To order Movicol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, Movicol provides a gentler, osmotic mechanism that softens stool without stimulating intestinal muscles. It is often preferred over lactulose for rapid relief, and it can be used alongside other treatments when a step‑wise approach to constipation is required.

Movicol should be stored at ambient temperature, below 25 °C, in its original container. Protect the solution from moisture and direct heat. Keep the bottle tightly closed when not in use to maintain product stability.

Movicol is supplied as an oral solution. The prescribed amount is typically mixed with a measured volume of water, stirred until fully dissolved, and then consumed. It should be taken as directed by a healthcare professional, usually with or without food.

Serious risks include severe electrolyte imbalance, which can cause cardiac or neurological symptoms, and allergic reactions such as rash, swelling or breathing difficulty. Patients experiencing these signs should seek immediate medical attention.

Movicol should be avoided in individuals with known hypersensitivity to any of its components, in patients with severe renal impairment without medical supervision, and in those with obstructive gastrointestinal conditions where increased stool water could worsen the blockage.